MedVi vs LTTL: Compare Pricing, Compounded Drugs, Support
Quick verdict: MedVi and LTTL both offer compounded GLP-1 options, but MedVi emphasizes a $179 promotional first month, 24/7 certified medical support, and an entirely online process, while LTTL highlights pharmacy verification, strength confirmation, and up to $140 off the first month. This comparison clarifies those key differences so you can choose.
Start MedVi $179 promotional first month
MedVi vs LTTL: What separates them
This direct comparison focuses on the most distinctive, sourced differences: promotional pricing and ongoing cost, the nature and regulatory note on compounded medication, clinical access and support model, and pharmacy verification and product testing. Each section contrasts MedVi and LTTL using only supplied facts.
1. Promotional pricing and ongoing cost
MedVi: MedVi advertises a winter promotional first-month price of $179 including fast, free shipping, with ongoing standalone months at $299 and a three-month plan at $649. LTTL: LTTL lists a starting price context of up to $140 off your first month with a code auto-applied and references price points like $249 and $129 in captured content. Exact ongoing terms and renewal details for LTTL were not published in full on the captured landing page.
Check LTTL first-month offer with auto-applied code
2. Compounded medication status and regulatory note
Both providers offer compounded GLP-1 therapies and both include the regulatory caveat: compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. MedVi specifically states its compounded semaglutide is produced in FDA-regulated facilities but is not FDA-approved, and urges discussion with a provider about risks and benefits. LTTL also includes the regulatory note that compounded medications are not FDA-approved.
3. Clinical access model and support
MedVi promotes a simple online intake with no clinic visits required and 24/7 support from certified medical professionals; an OpenLoop Health clinician reviews eligibility and retains prescribing discretion. LTTL describes clinician-reviewed online treatment available only when a licensed clinician determines it is medically appropriate, but the captured landing-page evidence did not publish a detailed support model comparable to MedVi’s 24/7 claim.
See MedVi online intake and 24/7 support
4. Pharmacy verification and product quality checks
LTTL emphasizes that its compounded medications are prepared in state-licensed pharmacies, independently verified in FDA-registered labs, and confirmed every 3 to 6 months to stay within plus or minus 10 percent of the target strength. MedVi states it is partnered with multiple USA certified pharmacies and that compounded GLP-1s are produced in FDA-regulated facilities, while noting compounded medications are not FDA-approved and may vary in appearance and testing.
5. Eligibility, published details, and what is not supplied
MedVi provides specific published pricing tiers, a description of the intake and clinician review process with OpenLoop Health, and outcome qualifiers based on self-reported patient data. LTTL captures promotional language and pharmacy verification claims but the captured affiliate landing page did not publish expanded FAQ answers or full details on state coverage, renewal terms, or some pricing specifics. Where details were absent for either provider, this article notes that the information was not supplied in the captured evidence.
| Criteria | MedVi | LTTL |
|---|---|---|
| First-month promo | $179 first month, fast free shipping | Up to $140 off first month, code auto-applied |
| Ongoing pricing | Standalone month $299; three-month plan $649 | Captured references to $249 and $129; full terms not published |
| Medication type | Clinically dosed compounded semaglutide only | Compounded GLP-1 full-dose options |
| Support and access | Simple online process, no clinic visits, 24/7 certified medical support | Clinician-reviewed online treatment; availability when medically appropriate |
| Pharmacy and testing | Partnered with USA certified pharmacies; notes compounds not FDA-approved | State-licensed pharmacies; independently verified in FDA-registered labs; strength confirmed every 3-6 months |
| Regulatory note | Compounded meds not FDA-approved or FDA-reviewed | Compounded meds not FDA-approved or FDA-reviewed |
How these differences affect your choice
If upfront promotional cost and 24/7 certified medical support with a no-clinic workflow matter most, MedVi’s advertised $179 first-month promo and online-only intake may be decisive. If independent lab verification, documented strength confirmation, and explicit pharmacy testing schedules are your priority, LTTL’s claims about state-licensed pharmacies and lab verification may be more relevant. Where details are missing for LTTL in the captured evidence, confirm eligibility, total cost, renewal terms and state availability directly with the provider.
Review LTTL pharmacy verification and testing claims
Compare MedVi program details and start online
Conclusion — MedVi vs LTTL
MedVi vs LTTL centers on pricing structure and support model versus pharmacy verification and testing claims. MedVi emphasizes a $179 promotional first month, a fully online process with 24/7 certified support, and published ongoing price tiers. LTTL emphasizes pharmacy compounding, independent lab verification, strength confirmation every 3 to 6 months, and up to $140 off the first month with a code auto-applied. Both note that compounded medications are not FDA-approved.
Choose MedVi if you want a simple online intake with 24/7 certified medical support and an advertised $179 promotional first month. Choose LTTL if independent pharmacy verification, lab testing, and documented strength confirmation are priorities and you will confirm state coverage, eligibility, and renewal terms before enrolling. This comparison used only supplied facts and preserved all stated qualifiers about compounded medications.